Target intelligence / Profile preview

Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein (HERPUD1)

Target
HERPUD1
Molecular classification
Endoplasmic reticulum (ER) membrane protein, Ubiquitin-like domain protein, Component of endoplasmic reticulum-associated degradation (ERAD) system (protein quality control machinery)
01

Overview

HERPUD1, or Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein, is a stress-inducible integral membrane protein of the endoplasmic reticulum. It is a component of the ER quality control machinery and ER-associated protein degradation (ERAD), participating in the recognition and ubiquitin-dependent disposal of misfolded proteins. HERPUD1 contains a pivotal ubiquitin-like domain (UBL) at its N-terminus, crucial for its regulated proteasomal degradation. Its expression is upregulated under ER stress and by the unfolded protein response (UPR). HERPUD1 interacts with ubiquilin and presenilin family members, impacting amyloid-beta production. Stabilized HERPUD1 downregulates autophagy, promotes ER remodeling into stacked tubular forms, and establishes ER-lysosome contact sites, which favor cell survival under stress conditions. It is implicated in neurodegenerative diseases due to its influence on amyloid-beta and is associated with cancer cell survival and adaptation to cellular stress, making it a relevant therapeutic target in cancer and possibly other proteinopathy-related diseases.

Other names
Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 proteinHERPUD1HERPKIAA0025MIF1 (MMF-inducible fragment protein 1)SUPMMS-inducibleHERPUD1 intronic transcript 1
02

Mechanism of action

Induction or inhibition of ER stress responses regulates HERPUD1 expression. Modulation of proteasomal degradation (i.e., proteasome inhibitors such as MG132 stabilize HERPUD1 levels). Possible modulation of autophagy, especially under stress or in cancer therapy.

03

Biological functions

Protein quality control in the ER (via ERAD)Regulation of unfolded protein response (UPR)Negative regulation of autophagy (when stabilized)ER remodeling and formation of ER-lysosomal networkInteraction with ubiquilin proteins, presenilins (impacts amyloid-beta generation)Cell survival under stressMay be involved in transmembrane transporter binding
04

Disease associations

Cancer (e.g., ovarian cancer: promotes cell survival by sustaining autophagy and inhibiting apoptosis)Neurodegenerative disease (increases amyloid-beta levels, potential relationship with Alzheimer’s disease)Hereditary breast ovarian cancer syndromeCellular stress-related diseases
05

Safety considerations

Overexpression of HERPUD1 enhances amyloid-beta production, suggesting a potential risk for neurodegenerative processesModulating HERPUD1 could impact critical ER stress/adaptive responses, risk of impaired protein homeostasis or cytotoxicityPossible effects on cell survival in malignant cells (cancer therapy resistance)
06

Interacting drugs

None directly listed in search results, but HERPUD1's role in ER stress/autophagy makes it indirectly modulated by agents affecting ER proteostasis or autophagic flux. Specific pharmacological inhibitors or inducers of ERAD, UPR, and autophagy pathways may alter HERPUD1 function.
07

Biomarkers

HERPUD1 expression may serve as a biomarker of ER stress or unfolded protein response activationIncreased HERPUD1 levels may correlate with cancer cell survival, autophagy, and ER remodeling

Beyond the preview

Go deeper on Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein (HERPUD1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein (HERPUD1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call